Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial board

    Page :A1

    
• • ·Table of contents

    Page :A4

    
• • ·Information for readers

    Page :A38

    
• • ·JAAD Case Reports article list

    Page :A39

    
• • ·Journal based CME instructions and information

    Page :A44

    

• Continuing Medical Education

  • ·Minimally invasive modalities for keratinocyte carcinomas—Part I: Diagnostics

    Page :1-18

    Patrick McMullan, Sarah Balboul, Nathan Gasek, Lauren Skudalski, Albert E. Zhou, Neelesh Patrick Jain, Nicholas Gulati, Silvana Ciardo, Francesca Farnetani, Brett Sloan, Jonathan Ungar, Jane M. Grant-Kels, Jonas A. Adalsteinsson

    Résumé Résumé Plan Plan  
  • ·CME examination

    Page :19

    
  • ·Answers to CME examination

    Page :20

    
  • ·Minimally invasive modalities for keratinocyte carcinomas —Part II: Treatment

    Page :21-48

    Nathan Gasek, Albert E. Zhou, Christian Gronbeck, Neelesh P. Jain, Sarah Balboul, Patrick McMullan, Lauren Skudalski, Nicholas Gulati, Jonathan Ungar, Jane M. Grant-Kels, Brett Sloan, Jonas A. Adalsteinsson

    Résumé Résumé Plan Plan
  • ·CME examination

    Page :49

    
  • ·Answers to CME examination

    Page :50

    

• Letter from the Editor

  • ·Selection bias

    Page :51

    Dirk M. Elston

    

• This Month in JAAD

  • ·This Month in JAAD: July 2026

    Page :52

    Dirk M. Elston

    

• Highlights from JAAD Case Reports

  • ·Highlights from JAAD Case Reports: July 2026

    Page :53

    Abby Susan Van Voorhees

    

• Highlights from JAAD International

  • ·Quality-of-life impact rather than overall severity may help guide therapeutic options in psoriasis

    Page :54

    Jonathan Kantor

    

• Highlights from JAAD Reviews

  • ·Highlights from JAAD Reviews: Nonpharmacologic and adjunctive treatments for nail psoriasis and androgenetic alopecia

    Page :55-56

    Shari R. Lipner

    

• A Clinician's Perspective

  • ·The wide world of glucagon-like peptide-1 agonist therapy: The thrill of weight loss and the agony of alopecia

    Page :57-58

    Warren R. Heymann

    

• Original Articles

  • ·Understanding factors impacting quality of life in patients with keratinocyte carcinoma: A cross-sectional analysis of Mohs surgery patients

    Page :59-69

    Evelyn Fagan, Joseph McGrath, Valerie K. Shostrom, Vanessa Voss, Adam Sutton

    Résumé Résumé Plan Plan
  • ·Comparative and complementary diagnostic value of dermatoscopy and clinical close-up photography in skin cancer diagnosis: A study from the MILK10k dataset

    Page :70-77

    Christoph Müller, Anna Wolber, Aimilios Lallas, Giuseppe Argenziano, Iris Zalaudek, H. Peter Soyer, Susana Puig, Bengu Nisa Akay, Ana Maria Forsea, Josep Malvehy, Ashfaq Marghoob, Zoe Apalla, Cliff Rosendahl, Konstantinos Liopyris, Ofer Reiter, Caterina Longo, Philipp Tschandl, Harald Kittler

    Résumé Résumé Plan Plan  
  • ·Infection risk among psoriasis biologic-new users: A cohort study on the French National Health Data System

    Page :78-86

    Tran Trong Khoi Le, Tat-Thang Vo, Emilie Sbidian

    Résumé Résumé Plan Plan  
  • ·A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis

    Page :87-94

    Yunlu Gao, Lanying Qin, Yumei Li, Yong Cui, Shifa Zhang, Lunfei Liu, Lihua Wang, Chao Ci, Jianyun Lu, Rixin Chen, Yanyan Feng, Shanshan Li, Chenghang Cai, Mingxia Chen, Han Han-Zhang, Yue Li, Lei Qian, Yuling Shi, CLEAR-1 Investigators

    Résumé Résumé Plan Plan  
  • ·Impact of early treatment of psoriasis on disease recurrence—Results from the STEPIn study

    Page :95-103

    Lars Iversen, Richard G. Langley, Johann E. Gudjonsson, Liv Eidsmo, Joanna Narbutt, Rafal Czajkowski, Andreas Pinter, Andrew E. Pink, Raquel Rivera-Diaz, Dheeraj A. Gianchandani, Frank Kolbinger, Weibin Bao, Corine Gaillez, Piotr Jagiello, Curdin Conrad

    Résumé Résumé Plan Plan  
  • ·Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: A cross-sectional study

    Page :104-111

    Jiayu He, Min He, Dehua Zhang, Ning Ning, Lin Chen, Shiyu He, Yunxia Ling, Jinfen Zheng, Xiangzi Li, Yang Guan, Yanyan Li

    Résumé Résumé Plan Plan  
  • ·Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi expert panel recommendations from ITSCC

    Page :112-120

    Nicole Loranger, Nicole Trepanowski, Payal Shah, Leora Aizman, Jennifer DeSimone, Stephanie Jackson Cullison, Fatemeh Jafarian, Kimberly M. Ken, Mary E. Lohman, Jennifer S. Ranario, Petra Rózsa, Vanessa B. Voss, Christina L. Chung, Manisha Loss, Katie A. O'Connell, Joi B. Carter

    Résumé Résumé Plan Plan

• From the Academy

  • ·Guidelines of care for the management of atopic dermatitis in pediatric patients

    Page :121.e1

    Dawn M.R. Davis, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, Robert Sidbury

    Résumé Résumé Plan Plan   
  • ·Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis

    Page :124.e1

    Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, Dawn M.R. Davis

    Résumé Résumé Plan Plan  

• Clinical Reviews

  • ·Immunosuppressive agents in solid organ transplantation: Cutaneous adverse effects and dermatologic considerations

    Page :127-137

    Olivia Marie Burke, Franco H. Cabeza, Jose A. Jaller, Jennifer C. Tang

    Résumé Résumé Plan Plan  
  • ·Acantholytic disorders: Update on pathophysiology, diagnosis, and management

    Page :138-147

    Maggie H. Zhou, Thomas P. Stirrat, John R. Edminister, Dirk M. Elston, Joseph Jorizzo, Kiran Motaparthi, Keyvan Nouri, Cory L. Simpson, Shari R. Lipner

    Résumé Résumé Plan Plan  
  • ·Adjunctive approaches for androgenetic alopecia: A clinical review of nutritional, light-based, topical, and lifestyle interventions

    Page :148-161

    Alexa S. Podolsky, Matilde Iorizzo, Kristen I. Lo Sicco, Antonella Tosti, Jerry Shapiro, Shari R. Lipner

    Résumé Résumé Plan Plan

• Brief Reports

  • ·Optimizing acitretin monitoring and discontinuation: A multicenter retrospective study on laboratory abnormalities, adverse effects, and post-treatment cutaneous squamous cell carcinoma risk

    Page :162-164

    Bina Kassamali, Madeline McNamara, Emily E. Karn, Shaman Bhullar, Sean R. Christensen, Emily S. Ruiz

     
  • ·The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigus

    Page :164-166

    Saan Youn, Vishvan Naidu, Ali Yalcinkaya, Harshita A. Jain, Yathavi Charavanamuttu, Nadira Ali, Kristina Semkova, Sophia N. Karagiannis, Jane Setterfield, Richard W. Groves, Thomas J. Tull

    Plan Plan  
  • ·Real-world outcomes and tolerability of Janus kinase inhibitors in chronic spontaneous urticaria and chronic inducible urticaria: A single-center retrospective study

    Page :166-169

    Yiqi Zhu, Wenli Zhang, Duoqin Wang, Sunyi Chen, Yixin Shao, Lisi Peng, Yanyun Shen, Hui Tang

     
  • ·Response to lebrikizumab in atopic dermatitis patients who failed upadacitinib: 48-week real-world outcomes

    Page :169-171

    Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

     
  • ·Higher levels of eosinophilia in erythroderma and suberythroderma correlate with a diagnosis of atopic dermatitis

    Page :171-173

    Marieta Papanikolaou, Sam Hughes, Hina Baloch, Kinari Patel, George W.M. Millington, Priya Subramanian

     
  • ·Early response to guselkumab and biologic-naïve status predict sustained efficacy with extended dosing intervals in mild-to-moderate plaque psoriasis: A real-world retrospective study

    Page :173-176

    Soomin Park, Sohee Oh, Hyun-Sun Yoon

    Plan Plan  
  • ·US expert opinions on the treatment of bullous pemphigoid based on guidelines from the European Academy of Dermatology and Venereology

    Page :176-178

    Michael Kasperkiewicz, Mishek Thapa, Prince Adotama, Mary M. Tomayko, Donna A. Culton

    Plan Plan  
  • ·Topical ruxolitinib for localized, steroid-refractory cutaneous immune-related adverse events: A single-institution real-world study

    Page :178-181

    Brandon R. Block, Jaanvi Mehta, Kateryna Karpoff, Hannah Verma, Raphaella A. Lambert, Grace Rabinowitz, Jade N. Young, Camille M. Powers, Nicholas Gulati

    Plan Plan
  • ·Real-world period prevalence of psoriatic disease 2015-2025: A cross-sectional study in the Epic Cosmos database

    Page :181-183

    Morten J. Lee, Maureen E. Canavan, Jeffrey M. Cohen

    
  • ·Quantifying the increased risk of atopic disorders in patients with ectodermal dysplasias: A nationwide registry-based study

    Page :183-186

    Laura K. Herlin, Mette Sommerlund, Sinéad M. Langan, Sigrun A.J. Schmidt

    Plan Plan
  • ·Occupational epidemic of Mycobacterium marinum infection in fishermen: Surgical pearls and multidisciplinary care of the invasive cases

    Page :186-188

    Yun Xiang, Xiao-Xi Xu, Su-Xiang Lin, Xing-Shi Zhang, Chun-Mei Qiu, Ling-Ling Ma, Dan Hu, Li Zheng, Yu-Ping Ran

    Plan Plan  
  • ·Dual-wavelength light-emitting diode plus acyclovir improves rash healing and pain control in elderly patients with acute herpes zoster: A multicenter, randomized, double-blind clinical trial

    Page :188-191

    Zixin Qiu, Ting Wang, Xianwen Liao, Shuiping Zeng, Yong Yan, Shiyang Li, Yu Xiao, Kemin Wang, Duyang Wang, Zhibin Zhang, Xianwei Cao

     
  • ·Distinct outcomes in localized versus generalized granuloma annulare: A retrospective cohort study highlighting subtype-specific management implications

    Page :191-193

    Congcong He, Pinyu Wen, Yuqing Zhang, Rui-qun Qi, Xing-Hua Gao

    
  • ·Occupational contact dermatitis in North American health care workers: Trends and triggers (2005-2022)

    Page :193-196

    Margo J. Reeder, Mayra Betancourt Ponce, Vijayram Patel, Erin M. Warshaw, Amber R. Atwater, Joel G. DeKoven, Brandon L. Adler, Donald V. Belsito, Jonathan I. Silverberg, James S. Taylor, Cory A. Dunnick, Peggy Wu, Jonathan Zippin, Vincent A. DeLeo, Christen M. Mowad, Marie-Claude Houle, Jiade Yu, Melanie D. Pratt, Nina Botto

    
  • ·Disparities in survival outcomes between Hispanic and non-Hispanic patients with metastatic cutaneous melanoma in the immunotherapy era: Insights from Surveillance, Epidemiology, and End Results database analysis

    Page :196-198

    Trang M. Nguyen, Tung S. Tran, Hue T. Tran, Svetomir N. Markovic, David A. Wetter, Clark C. Otley, Giang H. Nguyen

    Plan Plan  
  • ·Disparities in survival outcomes between married and unmarried patients with vulvar basal cell carcinoma: Insights from Surveillance, Epidemiology, and End Results database analysis (2000-2022)

    Page :198-201

    Hue T.T. Tran, Trang M. Nguyen, Katherine G. Holder, Raslina Shrestha, Jamie N. Bakkum-Gamez, Clark C. Otley, Giang H. Nguyen

     
  • ·Increasing incidence of cutaneous T-cell lymphoma among children and young adults in the United States, 1997-2019: A national poplation-based study using the National Childhood Cancer Registry

    Page :201-203

    Daniel Y. Kim, Timothy M. Dang, Jennifer T. Huang, Sasha Stephen, Thomas S. Kupper, Cecilia Larocca, Nicole R. LeBoeuf

     
  • ·Penile basaloid squamous cell carcinoma: Insights from the National Cancer Database (2004-2023)

    Page :204-206

    Hue T.T. Tran, Duc V. Le, Raslina Shrestha, Lance C. Pagliaro, Burak Tekin, Giang Huong Nguyen

     
  • ·HIV-related exclusion criteria in cutaneous cancer clinical trials

    Page :206-208

    William Goodman, Rebecca Goldberg, Carsten R. Hamann

    
  • ·Drug-associated paronychia: Pharmacovigilance signals from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) and the Canada Vigilance Adverse Reaction Database (CVARD)

    Page :208-211

    Duc V. Le, Hue T.T. Tran, David A. Wetter, Giang H. Nguyen

     
  • ·Risk and protective factors for uveal melanoma: Evidence for a protective role of autoimmune and immune-mediated conditions

    Page :211-214

    Charles Lu, Debby Cheng, Andrew Mu, Olivia Burke, Lirit Fuksman, Priya Katyal, Sara Khattab, Nga Nguyen, Emma Beagles, Crystal Chang, Suzanne Xu, Jonathan C. Hwang, Linden Huhmann, Nicholas Starink, Martin A. Weinstock, Maryam M. Asgari, Marc S. Hurlbert, John M. Gaziano, Nathanael R. Fillmore, Rebecca I. Hartman, Yevgeniy R. Semenov

    
  • ·One hundred and four-week real-world effectiveness of deucravacitinib 6 mg for genital, scalp, and nail psoriasis: A prospective study in Japan

    Page :214-216

    Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

     
  • ·A retrospective study of 308 Chinese nevus simplex patients: A nomogram predicting natural regression over time

    Page :216-218

    Xiaoxue Xing, Qinyi Chen, Yaqi Dong, Yijian Zhu, Chengfeng Zhang, Fang Yan, Zhong Lu, Leihong Xiang, Hui Qian, Jie Ren

    Plan Plan  
  • ·Insurance-driven switching and real-world treatment outcomes of Janus kinase inhibitors in alopecia areata: A retrospective cohort study

    Page :218-221

    Yumeng T. Engelking, Ali Jabbari

    Plan Plan  
  • ·Utility of 31-gene expression profile testing for predicting sentinel lymph node biopsy positivity in American Joint Commission on Cancer pT1b melanomas: Analysis of the Surveillance, Epidemiology, and End Results-DecisionDx database

    Page :221-222

    Tejas P. Joshi, Kavya Kannan, Rajiv I. Nijhawan

    
  • ·Changes in consult patterns, diagnostic concordance, and complexity in inpatient dermatology, 2016-2023: A repeated cross-sectional study of the Mass General Brigham Research Patient Data Registry

    Page :222-225

    Olivia Davies, Eric Xia, Farrah Leen Ezzeddine, Andrew Walls, Steven Chen, Arash Mostaghimi, Sotonye Imadojemu

    
  • ·The costs of superficial radiation therapy are greater than Mohs micrographic surgery for the treatment of nonmelanoma skin cancer: Analysis from the CMS provider and service data set

    Page :225-227

    Jeremy G. Light, Timothy J. Freeman, Aubriana McEvoy, Jordan Lim, Laurin Council, Jeff M. Michalski, Basia M. Michalski

    Plan Plan
  • ·Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy study

    Page :227-229

    Limin Sun, Chenghong Jiang, Shengmiao Li, Runsong Jiang, Yize Zhang, Shuling Chen, Mengjie Xu, Shih-Jen Chang, Linjun Yu, Baoli Su, Zichun Ma, Tian Wu, Yajing Qiu, Xiaoxi Lin

    Plan Plan  
  • ·Pain and scrotal involvement are associated with misdiagnosis in extramammary Paget disease: A retrospective cohort study

    Page :229-231

    Anjana Srikumar, Raghav Tripathi, Shirley Lin, Tara McCaffrey, Elena Wei, Joel Sunshine

    
  • ·Safety of dermatologic surgery during immune checkpoint inhibitor therapy

    Page :231-233

    Michael J. Davis, Megan Trager, Yassaman Erfani, Stephen Dusza, Alina Markova, Erica Lee, Kishwer Nehal, Karen Connolly

    
  • ·Association of doxycycline use for acne with sexually transmitted infection outcomes: A TriNetX retrospective cohort study

    Page :234-235

    Richard J. Moraga, Hannah L. Cole, Mitchell Hanson, Lisa Y. Shen, John S. Barbieri, John G. Zampella

    
  • ·Evaluating a sequential treatment strategy for recalcitrant warts: A time-dependent comparative study

    Page :235-237

    Byung Ho Oh

    Plan Plan  
  • ·Alopecia after glucagon-like peptide-1 agonist therapy: A TriNetX Database active comparator retrospective cohort study

    Page :238-240

    Kyle C. Lauck, Areeba Ahmed, Stanislav N. Tolkachjov

    
  • ·Frailty and survival outcomes in veterans with invasive cutaneous melanoma: A Veterans Affairs Cancer Registry retrospective cohort study

    Page :240-243

    Linden B. Huhmann, Jonathan C. Hwang, Daniel Y. Kim, Kaelyn Nannini, Nhan V. Do, John M. Gaziano, Lee E. Wheless, Nathanael R. Fillmore, Rebecca I. Hartman

    Plan Plan
  • ·Clinical outcomes of adalimumab treatment in dissecting cellulitis, along with pre- and post-treatment trichoscopic findings: A retrospective, multicentre study of 29 cases

    Page :243-246

    Aikaterini Bakirtzi, Andrea Sechi, Azael Freites-Martinez, Michela Starace, Bianca-Maria Piraccini, Leila Asfour, Dimitrios Sgouros, Alexander Katoulis, Stella Sakelaropoulou, Eirini Kyrmanidou, Elizabeth Lazaridou, Zoe Apalla

    
  • ·Risk of ocular disease in congenital epidermal differentiation disorder patients: A propensity matched cohort analysis of the TriNetX database

    Page :246-248

    Robert Adler, Michael Kozlov, Isha Gandhi, Manan D. Mehta, Emily Cowen, Katerina Svigos, Sharon A. Glick

    
  • ·Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with glucagon-like peptide-1 receptor agonists: A population cohort study from the TriNetX collaborative network

    Page :248-250

    Alina S. Feng, Jeffrey Zhang, Yoli Meydan, Wilson Liao

    Plan Plan  
  • ·Infections and hospitalizations in adolescents with atopic dermatitis treated with oral Janus kinase inhibitors: A cohort study using TriNetX

    Page :250-251

    Raymond Z. Ezzat, Meshi Paz, Li-Chi Chen, Divya Sharma, Caroline Kreytak, Maryanne M. Senna

    Plan Plan
  • ·Immunosuppressed patients undergoing Mohs micrographic surgery: A cross-sectional analysis of the MohsAIQ national data registry

    Page :252-255

    Nina A. Ran, Sunah Song, the Cleveland Institute for Computational Biology; and the MohsAIQ Data Release Working Group, Cleveland Institute for Computational Biology Team, MohsAIQ Data Release Working Group, Mark Beno, Beverly Koepf, Robert Lanese, Harry Menegay, Christian L. Baum, Bryan T. Carroll, Marc Carruth, Scott Collins, Dustin DeMeo, Pamela Gabrish, Katherine M.L. Given, Mollie MacCormack, Fatima N. Mirza, Howard W. Rogers, Adam Sutton, Raghav Tripathi, Lee E. Wheless, Oliver J. Wisco, Yang Xia, Emily S. Ruiz

    
  • ·Simple preventative skin care regimen helps patients undergoing targeted CNS or PNS therapy: A multicenter single-arm trial

    Page :255-257

    Danny Linggonegoro, Rebecca Levy, Tara McKeown, Julissa Jimenez, Erin McDonough, Madeline Hlobik, Lindsay McCormack, Hannah Song, Susan N. Chi, Nicole J. Ullrich, Wendy B. London, Nan Chen, Karina L. Vivar, Irene Lara-Corrales, Jennifer T. Huang

    Plan Plan
  • ·Epidermal growth factor receptor-targeted agents and paronychia: A US Food and Drug Administration Adverse Event Reporting System–based real-world pharmacovigilance analysis

    Page :257-260

    Siqi Sun, Hongfeng Mao, Yihe Yu, Jintao Ning, Yunlei Pan, Hongyu Jia

     
  • ·Safety outcomes of neuromodulator and dermal filler procedures in a dermatology resident cosmetic clinic

    Page :260-262

    Kristina Paré, Nathalia Simonetti, Grace McCollam, Leah Jacob, Brittany Stumpf, Andrea Murina

     
  • ·Younger age at melanoma diagnosis: a survey study of indoor tanning use

    Page :262-264

    Meghan Mahoney, Annie Wu, Haocheng Li, Danny Guo, Toni Burbidge, Eugene Batuyong, Susan Poleman, Matthew Ernst, Tina Cheng

    
  • ·Chemical peel injury: A retrospective database analysis of judicial precedents

    Page :264-267

    Ghassan Barnawi, Christopher Shenouda, Zainab Ridha, Ammar Saed Aldien, Rachel Creighton, Raquel Lazarowitz, Ian T.Y. Wong, Saud Aleissa, Mathew Avram, Shari R. Lipner

    
  • ·Associations between obesity and confluent and reticulated papillomatosis: A single-center retrospective matched cohort study

    Page :267-269

    Judy Shan, Brandon K. Chu, Justin Cheng, Katrina Abuabara, Sarah J. Coates

    
  • ·Reduced prostate cancer risk in patients with androgenetic alopecia using 5-alpha reductase inhibitors: A TriNetX real-world cohort study

    Page :269-271

    Yu-Jen Chen, Wei-Ting Liu, Chao-Chun Yang

    
  • ·Antibiotics prior to immune checkpoint inhibitor therapy worsens survival in Merkel cell carcinoma: A TriNetX retrospective cohort study

    Page :271-274

    Alan Shen, Jacky H.K. Chen, David C. Kaelber, Amy S. Nowacki, Joshua Arbesman

     
  • ·Relative survival analysis of dermatofibrosarcoma protuberans, Kaposi sarcoma, and pleomorphic sarcoma across intersectional demographics: A Surveillance, Epidemiology, and End Results (SEER) study

    Page :274-277

    Benjamin D. Hu, Andrew Zhu, Raphaella Lambert, Brandon R. Block, Grace Rabinowitz, Hannah Verma, Jón Gunnlaugur Jónasson, Bardur Sigurgeirsson, Shane Meehan, Jonathan Ungar, Jesse M. Lewin, Nicholas Gulati, Jonas A. Adalsteinsson

     
  • ·Framing bias in a large language model: Prompt framing influences ChatGPT's accuracy in melanoma classification. A diagnostic accuracy study

    Page :277-279

    Daniele Omar Traini, Gerardo Palmisano, Alessandro Di Stefani, Ketty Peris

     
  • ·Enhancing dermatology workflow through a replicable epic-based module: Impact on documentation and after-hours electronic medical record use

    Page :279-281

    Simona A. Alomary, Nicole J. Baker, Susan C. Taylor, Nicholas K. Mollanazar

     
  • ·Buddy Relationships in Dermatologic Excisions for Skin Cancer: A feasibility study of one-to-one peer mentorship in patients with facial skin cancers treated with Mohs micrographic surgery

    Page :281-283

    Shannon W. Zullo, Shannon T. Nugent, Maija Bruzas, Tess M. Lukowiak, William C. Fix, Christopher J. Miller, Jeremy R. Etzkorn, Thuzar M. Shin, Joseph F. Sobanko

    
  • ·Sex and tumor location outcomes in Merkel cell carcinoma: A retrospective cohort study utilizing Mayo Clinic Platform

    Page :283-286

    Sarah A. Amjad, Jenna E. Koblinski, Micah Starghill, Samantha Shao, Jacob Breinholt, Christopher J. Arpey, Christian L. Baum, Phillip Pirgousis, Roxana S. Dronca, Aaron R. Mangold, James W. Jakub, Collin M. Costello

    Plan Plan
  • ·Single site retrospective series on patients with purpura fulminans: Novel finding of solid organ transplantation as a risk factor

    Page :286-287

    Emily C. Fischbach, Alexandra J. Coromilas, Stephanie M. Gallitano

    
  • ·Perioperative racial disparities in patients with acral lentiginous melanoma undergoing Mohs micrographic surgery: A single-institution retrospective cohort study

    Page :287-290

    Umayr R. Shaikh, Christopher G. Richter, Leela K. Raj, Daniela Kapoor, Karla Valdes-Morales, Mara Trifoi, Simona A. Alomary, Nicole Baker, Aditi Senthilnathan, Dylan Haynes, Susan C. Taylor, Christopher J. Miller, Jeremy R. Etzkorn, Joseph Sobanko, Junqian Zhang, Joanna Walker, H. William Higgins

    
  • ·Comparative hepatotoxicity of systemic antifungals in onychomycosis patients with chronic liver disease: A TriNetX retrospective cohort study

    Page :290-291

    Rebecca Zhang, Hong Ye, Shari R. Lipner

    
  • ·Better early treatment response to dupilumab in intrinsic atopic dermatitis

    Page :292-294

    Pei-Yu Wang, Tian-Hang Yu, Guang-Wen Yin, Lin-Feng Li

    
  • ·Rituximab versus mycophenolate mofetil or azathioprine for cancer risk in pemphigus: A population-based emulated target trial

    Page :294-296

    Arjun Mahajan, Avery H. LaChance, Nathaniel S. Treister, Kevin Sheng-Kai Ma, Steven T. Chen

    

• Health Policy & Practice

  • ·Breaking the Sunscreen Bottleneck: Regulatory Reform and Clinical Impact

    Page :297-298

    Malak Husseinali, Dina Zamil, Tejas P. Joshi, Rishabh Lohray, Ida Orengo

    
  • ·The Wasteful and Inappropriate Service Reduction model and its potential impacts on dermatologic care

    Page :299-301

    Arjun Mahajan, Maureen Whittelsey, Vinod E. Nambudiri, Avery H. LaChance

    

• Controversies

  • ·Pros of artificial intelligence in dermatology

    Page :302-303

    Timothy Klufas, Albert E. Zhou, Jane M. Grant-Kels

    Plan Plan
  • ·Cons of Artificial Intelligence as a Diagnostic Aid in Dermatology: A Threat to Quality of Care and the Role of the Dermatologist

    Page :304-305

    Sidra Ibad, Christian Gronbeck, Cliff Perlis

    

• Dermatology Images

  • ·Cutaneous manifestations of tuberous sclerosis complex in adults

    Page :306-320

    Sanyam Mehta, Kailash Bhatia, Chaitanya Namdeo

    Plan Plan  
  • ·Syphilis: The great imitator in dermatologic presentation

    Page :321-335

    Zhen Li, Fangfang Bao, Rongtao Zheng, Jianling Hou, Tongsheng Chu, Dianchang Liu, Na Huang, Hongqing Tian

     

• Humanities

  • ·Mad fashion: Current regulations governing chemicals in clothing

    Page :336-337

    Eryn Patin, Kathyana P. Santiago Mangual, Jenny E. Murase, Arianne Shadi Kourosh

    
  • ·Melanoma outcome disparities in minority populations and the need for inclusive clinical trials for the benefit of all

    Page :338-339

    John Strasswimmer

    

• Medical Error & Patient Safety

  • ·A nationwide analysis of skin cancer malpractice precedents in the United States 1930-2025

    Page :340-342

    Ghassan Barnawi, Elsa Awad, Raquel Lazarowitz, Ammar Saed Aldien, Houriah Nukaly, Saud Aleissa, Nehal S. Kishwer, Mathew Avram

     

• Beyond JAAD

  • ·Beyond JAAD: July 2026

    Page :343-346

    Andrew Bronin

    Plan Plan

• Correction

  • ·Correction

    Page :347

    

• JAAD Online

  • ·Challenges of acne management in aviation careers

    Page :e1

    Aarushi K. Parikh, Shari R. Lipner

    
  • ·Ethical accountability for artificial intelligence–written manuscripts in dermatology

    Page :e3

    İsmail Hakkı Ünal, Gustavo Freitas, Jane M. Grant-Kels

    
  • ·Predictive dermatology and patient autonomy: Navigating unvalidated genetic data in clinical practice

    Page :e5

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Janice Kim, Jane M. Grant-Kels

    
  • ·Ethics of school and work accommodations in psychosocial management of hidradenitis suppurativa

    Page :e7

    Chelsea Deitelzweig, Benjamin K. Stoff, Lauren Orenstein, Marissa L.H. Baranowski

    
  • ·Addressing tattoo removal ethics for patients with coerced tattoos

    Page :e9

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Janice Kim, Jane M. Grant-Kels

    
  • ·Dermatologists and environmental exposures: Ethical duties beyond patient care

    Page :e11

    Isabella J. Tan, Sophia Ma, Tarek Zieneldien, Jane M. Grant-Kels

    
  • ·Physician responsibility in complementary and alternative medicine: Beyond acknowledging limitations

    Page :e13

    Kritin K. Verma, Dora Ryan Goldstein, Michelle B. Tarbox, Steven Daveluy

    
  • ·Skin cancer screening in blind and visually impaired patients

    Page :e15

    Varshini Babu, Zelma Chiesa Fuxench, Emily Baumrin

    
  • ·Beyond the visit: Ethical responsibilities for sustainable volunteer dermatology outreach

    Page :e17

    Esther O. Nwozo, Beverly Udegbe, Nicole A. Negbenebor

    
  • ·Ethics of excluding transgender and gender-diverse patients from clinical research

    Page :e19

    Adam Zimmer, Leah D. Kovacs, Albert Zhou, Markus Boos, Jane M. Grant-Kels

    
  • ·Balancing hierarchy and patient safety in dermatology residency

    Page :e21

    Aarushi K. Parikh, Alexandra Flamm, Shari R. Lipner

    
  • ·Sustaining ethics and compassion in palliative dermatology through maintaining balance between professional presence and self-preservation

    Page :e23

    Tarek Zieneldien, Sophia Ma, Isabella J. Tan, Janice Kim, Jane M. Grant-Kels

    
  • ·The ethics of expedited access: Concierge care in academic dermatology

    Page :e25

    Ayushya Ajmani, Albert E. Zhou, Jane M. Grant-Kels, Daniel M. Klufas

    
  • ·Ethical challenges of misinterpreting traditional skin practices

    Page :e27

    Isabella J. Tan, Sophia Ma, Tarek Zieneldien, Jane M. Grant-Kels

    
  • ·Ethics of device-specific requests in cosmetic dermatology: Balancing patient satisfaction and optimal results

    Page :e29

    Lily Park, Suzanne L. Kilmer, Jane M. Grant-Kels, Mathew M. Avram

    
  • ·Ethical considerations regarding environmental impact of generative artificial intelligence in dermatology

    Page :e31

    Joseph Ebriani, Matthew J. Yan, Jenna Lester, Mehdi Farshchian, Shannon Wongvibulsin

    
  • ·Burned by misinformation: Ethics of communication after dermatologic product recalls

    Page :e35

    Isabella J. Tan, Tarek Zieneldien, Sophia Ma, Janice Kim, Farah Succaria, Jane M. Grant-Kels

    
  • ·Ethical implications of artificial intelligence language interpretation tools in dermatology

    Page :e37

    Ghassan Barnawi, Raquel Lazarowitz, Houriah Nukaly, Sarah Kashkari, Shari R. Lipner

    
  • ·The ethics of commercializing surgical discards

    Page :e39

    Rania Djemil, Lanah Almatroud, Amor Khachemoune

    
  • ·Ethical considerations of medical student and resident contributions to article processing charges

    Page :e41

    Raquel Lazarowitz, Ghassan Barnawi, Houriah Nukaly, Isha Gandhi, Shari R. Lipner

    
  • ·^{A digital cap for nail protection from trauma}

    Page :e43

    Dustine Reich, Shari R. Lipner

    Plan Plan  
  • ·Using a 5-mL syringe to dislodge punch biopsy specimens: A simple technique for stuck tissue

    Page :e45

    Amandeep Saluja, Kriti Maheshwari

    Plan Plan  
  • ·Use of Wood's lamp for suture identification

    Page :e47

    Jessica Bulluss, Matthew Verheyden, Sarah Nowak, Vivian Tng

     
  • ·UV dermoscope used as a Wood’s lamp reveals “invisible” pityriasis versicolor

    Page :e49

    Rishi Malhotra, Anubha Dev, Manju Daroach

     
  • ·Can we navigate the pitfalls of tofacitinib randomized controlled trials in vitiligo? Addressing long-term safety and generalizability for enhanced clinical translation

    Page :e51

    Canni Gao, Xinxin Duan, Leixuan Peng, Pan Li, Kuanhou Mou

    
  • ·Response to Gao et al’s “Can we navigate the pitfalls of tofacitinib RCTs in vitiligo? Addressing long-term safety and generalizability for enhanced clinical translation”

    Page :e53

    Anubha Dev, Hitaishi Mehta, Keshavamurthy Vinay

    
  • ·Response to He et al's “Comments on ‘Optimized combination: Isotretinoin in conjunction with oral tranexamic acid for the treatment of moderate to severe acne vulgaris—A randomized, double-blind, placebo-controlled trial’”

    Page :e55

    Bingyang Xu, Jiawen Wu

    
  • ·Response to Bingyang Xu et al’s “Optimized combination: Isotretinoin in conjunction with oral tranexamic acid for the treatment of moderate to severe acne vulgaris—A randomized, double-blind, placebo-controlled trial”

    Page :e57

    Keren He, Haonan Wang, Yi Cao

    
  • ·Response to Sahin et al: Community engagement is critical for addressing disparities

    Page :e59

    Katlin T. Wilson, Justin P.C. Rehwaldt, Lucinda Kohn

    
  • ·Dermoscopic diagnostic limitations extend beyond ChatGPT into other large language models

    Page :e61

    Isha Gandhi, Rashika Shetty, Lana Kamel, Ruizhi Zhang, Nick Dol, Robert Adler, Chase Fishman, Steven Fishman

    
  • ·Comment on “Gene expression profiling in dermatology, part 2: Clinical applications—Toward safe, patient-centered implementation”

    Page :e63

    Yixuan Li, Ying Wang

    
  • ·Response to Li et al’s “Comment on ‘Gene expression profiling in dermatology, part 2: Clinical applications’—toward safe, patient-centered implementation”

    Page :e65

    Stanislav N. Tolkachjov

    
  • ·Impacts of AI scribing on premedical students: Comment on “Implications of artificial intelligence scribe usage”

    Page :e67

    Alexsandra E. Smith, Lauren E. Kozlowski, Wanhong Zheng, David Rich, Michael S. Kolodney, Gangqing Hu

    
  • ·Response to Hu et al, “Impacts of AI scribing on premedical students”

    Page :e69

    Timothy Klufas, Albert E. Zhou, Camilla Lee, Shannon Hanggodo, Erica Negrini, Jane M. Grant-Kels

    
  • ·Reply to Woodie et al, “Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX”

    Page :e71

    Tiago Torres, Andrew Blauvelt, Bruce Strober, Peter van de Kerkhof, Guy S. Eakin, Kevin Winthrop, Joel M. Gelfand

    
  • ·Reply to Torres et al, “Reply to Woodie et al, ‘Elevated risk of active tuberculosis with interleukin-17, interleukin-23, interleukin-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX’”

    Page :e73

    Brad R. Woodie, Justin A. Freking, Gabrielle M. Rivin, Alan B. Fleischer

    
  • ·Response to Park et al “On the clinical use of hair diameter diversity in androgenetic alopecia”

    Page :e77

    Samuel Tringali

    
  • ·Response to Tringali et al, “Response to Park et al on the clinical use of hair diameter diversity in androgenetic alopecia”

    Page :e79

    Do-Young Kim, Jemin Kim

    
  • ·Response to Jia et al’s “Comment on the “Genetic classification helps with precise sirolimus treatment in slow-flow vascular malformations””

    Page :e81

    Hongyuan Liu, Jun Zhu, Yuxi Chen, Xiaoxi Lin, Chen Hua, Hui Chen

     
  • ·Comment on the “Genetic classification helps with precise sirolimus treatment in slow-flow vascular malformations”

    Page :e85

    Hechen Jia, Weixin Wang, Xiaonan Yang

    
  • ·Rethinking oral minoxidil: Distinguishing the hair-growth window from the cardiovascular threshold

    Page :e87

    Raymond Z. Ezzat, Meshi Paz, Kristen I. Lo Sicco, Maryanne M. Senna

    Plan Plan  
  • ·Biologic therapy in tuberculosis-endemic regions: A clinical consideration

    Page :e89

    Sibel Altunisik Toplu, Nihal Altunisik, Dursun Turkmen

    
  • ·Response to Dr Turkmen “Abrocitinib safety in geriatric patients: The need for a holistic assessment”

    Page :e91

    Zhouwei Wu

    
  • ·Abrocitinib safety in geriatric patients: The need for a holistic assessment

    Page :e93

    Funda Datli Yakaryilmaz, Dursun Turkmen, Nihal Altunisik

    
  • ·Radiologic imaging in high-risk cutaneous squamous cell carcinoma: Clarifying the role beyond selection bias

    Page :e95

    Mingchen Xie, Haitao Wu, Jian Xu

    
  • ·Response to Xie et al, “Radiologic imaging in high-risk cSCC: Clarifying the role beyond selection bias”

    Page :e97

    Angela H. Wei, Lydia Cassard, Cong Fan, Sokhna Seck, Marla Rodriguez Vazquez, Jim Bena, Todd Stultz, Shlomo A. Koyfman, Allison T. Vidimos

    
  • ·Response to Qing et al, “Deepening the childhood atopic dermatitis-maternal depression link for clinical translation”

    Page :e99

    Hannah Kang, Ahnna Lee, Sheng-Pei Wang, Morgan Ye, Korey Capozza, Ashley Wimberly Ellis, Angela Fox, Kaja Z. LeWinn, Katrina Abuabara

    
  • ·Deepening the childhood atopic dermatitis-maternal depression link for clinical translation

    Page :e101

    Guangwei Qing, Hanggai Taorigen, Gang Wang

    
  • ·July 2026 IOTADERMA (#389)

    Page :e103

    Robert I. Rudolph